Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres:

2021 
Background:Oral cladribine has been approved for the treatment of relapsing multiple sclerosis (MS) yet real-world evidence regarding its effectiveness and safety remains scarce.Objective:To evalua...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    22
    References
    2
    Citations
    NaN
    KQI
    []